Vetnostrum Animal Health Co., Ltd. (TPE:6936)

Market Cap	2.48B +0.5%
Revenue (ttm)	1.37B +11.8%
Net Income	119.57M +10.1%
EPS	1.72 +5.8%
Shares Out	72.76M
PE Ratio	19.78
Forward PE	n/a
Dividend	1.69 (4.76%)
Ex-Dividend Date	Jul 16, 2025

Volume	26,899
Average Volume	72,761
Open	35.80
Previous Close	35.45
Day's Range	35.40 - 35.80
52-Week Range	34.00 - 51.10
Beta	0.08
RSI	24.53
Earnings Date	Mar 25, 2026

About Vetnostrum Animal Health

Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Taichung, Taiwan. Vetnostrum Animal Health Co., Ltd. ope...

• Industry: Farm Products
• Sector: Consumer Staples
• Founded: 2012
• Employees: 170
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6936

Financial Performance

In 2024, Vetnostrum Animal Health's revenue was 1.29 billion, an increase of 7.17% compared to the previous year's 1.21 billion. Earnings were 136.62 million, an increase of 49.15%.